News

Freeline Announces Proposed ADS Ratio Change

LONDON, April 21, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it plans to change…

2 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

CALGARY, Alberta, April 21, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

2 years ago

StateHouse Confirms Extension of Series A Debt Obligations to May 22nd, 2023

SAN DIEGO and TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. ("StateHouse" or the "Company") (CSE: STHZ) (OTCQX:…

2 years ago

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging…

2 years ago

Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023

        Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31,…

2 years ago

Burning Rock Publishes 2022 Annual Report on Form 20-F

GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or…

2 years ago

Jushi Holdings Inc. Announces Change of Auditor

BOCA RATON, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),…

2 years ago

Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen

Company Announcement COPENHAGEN, Denmark; April 21, 2023 – Genmab A/S (Nasdaq: GMAB) announced today an award in the second arbitration…

2 years ago

InkSpace Imaging Welcomes Howard Peters as Vice President of Sales and Marketing

PLEASANTON, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leading provider of advanced medical imaging solutions, is thrilled…

2 years ago

Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split

Vallon’s board approves 1-for-30 reverse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE…

2 years ago